⌘K

Login Start Free

Home/Filings/4/0001790340-25-000127

4//SEC Filing

Feinberg Peter 4

Accession 0001790340-25-000127

CIK 0001790340other

View on SEC.gov Company Profile

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 8:56 AM ET

Size

6.8 KB

Accession

0001790340-25-000127

Insider Transaction Report

Form 4

Period: 2025-10-03

Immuneering CorpIMRX

Director

Transactions

Purchase
Class A Common Stock
2025-10-03$6.67/sh+7,500$50,025→ 156,766 total

Holdings

Class A Common Stock
(indirect: General Partner of PF Associates L.P.)
392,242
Class A Common Stock
(indirect: By LLC)
115,441
Class A Common Stock
(indirect: By LLC)
476,615

Documents

1 file

4
wk-form4_1759841769.xmlPrimary
FORM 4

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1

filerCIK 0001870076

Filing Metadata

Form type: 4
Filed: Oct 6, 8:00 PM ET
Accepted: Oct 7, 8:56 AM ET
Size: 6.8 KB

View on SEC.gov